Guided Therapeutics (GTHP) Change in Inventory (2012 - 2025)
Guided Therapeutics (GTHP) reported Change in Inventory of -$135000.0 for Q4 2025, down 4400.0% on a YoY basis from $3139.5 in Q4 2024, and down 1025.0% sequentially from -$12000.0 in Q3 2025.
Guided Therapeutics (GTHP) Change in Inventory (2012 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 14 years of Change in Inventory data on file, last reported at -$135000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory fell 4400.0% year-over-year to -$135000.0; the trailing twelve-month figure through Dec 2025 stood at -$185000.0 (down 18600.0% YoY), and the FY2025 full-year result was -$185000.0, down 18600.0% from the prior year.
- Change in Inventory slipped to -$135000.0 in Q4 2025, from -$12000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $74000.0 in Q3 2023 to a low of -$135000.0 in Q4 2025.
- A 5-year average of -$4411.8 and a median of -$1000.0 in 2021 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory surged 6000.0% in 2023 and plunged 4400.0% in 2025, its largest moves.
- Tracing GTHP's Change in Inventory over 5 years: stood at -$47000.0 in 2021, then soared by 170.21% to $33000.0 in 2022, then sank by 145.45% to -$15000.0 in 2023, then soared by 80.0% to -$3000.0 in 2024, then sank by 4400.0% to -$135000.0 in 2025.
- Business Quant data shows GTHP's Change in Inventory at -$135000.0 in Q4 2025, -$12000.0 in Q3 2025, and -$38000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | -135,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -135,000.00 |
| Dec 31, 2025 | -135,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -38,000.00 |
| Jun 30, 2025 | -38,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | 74,000.00 |
| Sep 30, 2023 | 74,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | -36,000.00 |
| Mar 31, 2023 | -36,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Dec 31, 2022 | 33,000.00 |